Volume | 180,739 |
|
|||||
News | - | ||||||
Day High | 2.73 | Low High |
|||||
Day Low | 2.28 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Ampio Pharmaceuticals Inc | AMPE | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.36 | 2.28 | 2.73 | 2.28 | 2.67 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,232 | 180,739 | $ 2.45 | $ 443,393 | - | 1.86 - 8.298 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
20:00:00 | 400 | $ 2.28 | USD |
Ampio Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
24.96k | 832.02k | - | 0 | -16.34M | -19.64 | 0.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ampio Pharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMPE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.13 | 7.47 | 1.86 | 5.60 | 4,122,927 | 0.15 | 7.04% |
1 Month | 2.50 | 7.47 | 1.86 | 5.50 | 1,125,468 | -0.22 | -8.8% |
3 Months | 5.00 | 7.47 | 1.86 | 5.41 | 380,881 | -2.72 | -54.4% |
6 Months | 5.80 | 8.298 | 1.86 | 5.03 | 426,328 | -3.52 | -60.69% |
1 Year | 6.20 | 8.298 | 1.86 | 5.05 | 350,018 | -3.92 | -63.23% |
3 Years | 318.00 | 894.00 | 1.86 | 262.76 | 2,439,700 | -315.72 | -99.28% |
5 Years | 186.00 | 894.00 | 1.86 | 244.50 | 2,083,451 | -183.72 | -98.77% |
Ampio Pharmaceuticals Description
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress. |